EFFORTS TOWARDS SYNTHESIS OF HYDROGEN SULFIDE ACTIVATED BODIPY BASED PDT AGENT

2022-5-13
Canyurt, Merve
Photodynamic Therapy (PDT) is an effective and minimally invasive method that has recently gained widespread acceptance as a new medical treatment for a variety of conditions. PDT uses photosensitizers in combination with a specific light source and molecular oxygen to form cytotoxic species that can damage organelles and cell membranes directly. The photodynamic reactions start with light absorption by the PS in the target tissue, which sets off a chain of photochemical events. In comparison to existing sensitizers, BODIPY (4,4-difluoro-4-bora-3a,4a-diaza-s-indacene) allows for the creation of next-generation photosensitizers due to their high fluorescence and triplet quantum yields, ease of functionalization, and tunable photophysical properties. The aim of this project is to synthesize two different water-soluble, mitochondria-targeted and activatable photosensitizers. For this purpose, brominated BODIPY core is modified at different positions with pyridinium unit and azido-benzyl masking unit which is activated with H2S, an over-expressed tumor metabolite. In the first sensitizer (S-BODMe), two consecutive Knoevenagel condensation processes were attempted to introduce pyridinium unit to the 5-position and the corresponding protected aldehyde to the 3-position which would have been deprotected and modified with the masking unit for H2S activation. Unfortunately, the target molecule could not be attained. In the second approach (S2-BODMe), the pyridine unit was incorporated to the bromo-BODIPY core and the aldehyde incorporation was introduced with a double Knoevenagel condensation reaction successfully, but insertion of the azido-based masking unit could not be accomplished. Later on, azido-based masking group was successfully attached to the corresponding aldehyde. As a future work, this new aldehyde containing masking unit will be used to modify the bromo-BODIPY core, followed by methylation of the pyridine unit to attain the target molecule.

Suggestions

Near-IR absorbing BODIPY derivatives as glutathione-activated photosensitizers for selective photodynamic action.
Turan, IS; Cakmak, FP; Kahraman, Deniz Cansen; Atalay, Rengül; Akkaya, EU (2014-12-01)
Enhanced spatiotemporal selectivity in photonic sensitization of dissolved molecular oxygen is an important target for improving the potential and the practical applications of photodynamic therapy. Considering the high intracellular glutathione concentrations within cancer cells, a series of BODIPY-based sensitizers that can generate cytotoxic singlet oxygen only after glutathione-mediated cleavage of the electron-sink module were designed and synthesized. Cell culture studies not only validate our design,...
Superior Photodynamic Therapy of Colon Cancer Cells by Selenophene-BODIPY-Loaded Superparamagnetic Iron Oxide Nanoparticles
Ozvural Sertcelik, Kubra Nur; Karaman, Osman; Almammadov, Toghrul; Günbaş, Emrullah Görkem; Kolemen, Safacan; Yagci Acar, Havva; Onbasli, Kubra (2022-01-01)
© 2022 Wiley-VCH GmbH.Development of targeted nanoparticles as carriers to deliver photosensitizers to cancer cells is highly beneficial for ensuring the expected therapeutic outcome of photodynamic therapy. Herein, polyacrylic acid (PAA) coated superparamagnetic iron oxide nanoparticles (SPIONs), conjugated with endothelial growth factor receptor (EGFR) targeting Cetuximab (Cet) were loaded with a BODIPY-based (BOD-Se-I) photosensitizer (Cet-PAA@SPION/BOD-Se-I) to achieve enhanced and selective photodynami...
Decision support system for Warfarin therapy management using Bayesian networks
Yet, Barbaros; Raharjo, Hendry; Lifvergren, Svante; Marsh, William; Bergman, Bo (2013-05-01)
Warfarin therapy is known as a complex process because of the variation in the patients' response. Failure to deal with such variation may lead to death as a result of thrombosis or bleeding. The possible sources of variation such as concomitant illnesses and drug interactions have to be investigated by the clinician in order to deal with the variation. This paper describes a decision support system (DSS) using Bayesian networks for assisting clinicians to make better decisions in Warfarin therapy managemen...
Selective monitoring and treatment of neuroblastoma cells with hydrogen sulfide activatable phototheranostic agent
Dirak, Musa; Kepil, Dilay; Almammadov, Toghrul; Elmazoglu, Zubeyir; Cetin, Sultan; Ozogul, Naz; Günbaş, Emrullah Görkem; Kolemen, Safacan (2023-02-01)
Activity-based photosensitizers (aPSs) are highly attractive as they offer improved selectivity and better therapeutic outcome in the scope of photodynamic therapy (PDT). Here, a hydrogen sulfide (H2S) responsive iodinated resorufin-based PS (RHS) was developed to treat neuroblastoma cancer cells selectively. RHS was shown to be a phototheranostic agent as it turned on its fluorescence signal and singlet oxygen (1O2) generation capability after reacting with H2S. RHS exhibited remarkable sensitivity towards...
Alternative Polyadenylation patterns for novel gene discovery and classification in cancer
Beğik, Oğuzhan; Öyken, Merve; Can, Tolga; Erson Bensan, Ayşe Elif (2017-06-03)
Certain aspects of diagnosis, prognosis and treatment of cancer patients are still important challenges to be addressed. Therefore, we propose a pipeline to uncover patterns of alternative polyadenylation (APA), a hidden complexity in cancer transcriptomes, to further accelerate efforts to discover novel cancer genes and pathways. Here, we analyzed expression data for 1,045 cancer patients and found a significant shift in usage of poly(A) signals in cancers. Using machine-learning techniques, we further def...
Citation Formats
M. Canyurt, “EFFORTS TOWARDS SYNTHESIS OF HYDROGEN SULFIDE ACTIVATED BODIPY BASED PDT AGENT,” M.S. - Master of Science, Middle East Technical University, 2022.